BU-NOT-SET

CONTACT US
Getting on track with FMD
  • Manufacturing
Eyes
Insight
The advantages of modified release oral dosage forms
  • Drug product
Eyes
Insight
Streamlining scale-up for drug substances
  • Drug substance
Filling
Insight
Oral solids endure and evolve
  • Drug product
Eyes
Insight
Patient-centric drug development comes of age
  • Drug product
Eyes
Insight
Looking beyond the deadline
  • Manufacturing
Eyes
Insight
Modified release formulations: improving efficacy and patient compliance
  • Drug product
Eyes
Insight
FMD: industry thoughts as serialisation deadline nears
  • Manufacturing
Eyes
Insight
Sustainability report 2019
  • Sustainability
Report
Report
Insight
  • Sustainability
Is it time to introduce science based targets for climate change?
Insight
  • Drug product
  • Industry trends
Addressing the key pitfalls hindering technology transfer success
Case study
  • Analytical chemistry
  • Drug product
Overcoming tablet dissolution challenges with formulation expertise
Insight
  • Industry trends
  • Manufacturing
Today’s potent oral dose forms require flexible manufacturing environments
Insight
  • Analytical chemistry
  • Drug product
Benefits of reformulation strategies
Case study
  • Drug product
  • Manufacturing
Supporting first lyophilised mRNA vaccine to pivotal trial
Fact sheet
  • Drug product
  • Manufacturing
LAB+ blow-fill-seal system
Insight
  • Drug product
  • Manufacturing
How process innovation helped rapidly overcome mRNA drug product finishing and dispensing challenges
Insight
  • Biologics
Bringing virotherapy forward